Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia
http://investors.axovant.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
2 seconds
PAGES IN
THIS WEBSITE
11
SSL
EXTERNAL LINKS
91
SITE IP
52.85.77.167
LOAD TIME
2 sec
SCORE
6.2
Investors – Axovant Sciences | investors.axovant.com Reviews
https://investors.axovant.com
Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia
investors.axovant.com
Axovant Sciences to Present at the 35th Annual J.P. Morgan Healthcare Conference – Axovant Sciences
http://investors.axovant.com/investors/press-releases/2016/12-15-2016-130332274
Skip to main content. Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Axovant Sciences to Present at the 35th Annual J.P. Morgan Healthcare Conference. Axovant Sciences to Present at the 35th Annual J.P. Morgan Healthcare Conference. Dec 15, 2016 /PRNewswire/ - Axovant Sciences (NYSE: AXON. A replay will be available for 30 days following the conference. To vie...
Email Alerts – Axovant Sciences
http://investors.axovant.com/investors/email-alerts
Skip to main content. Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Fill out the form below to sign up for Axovant's investor email alerts. If you would like to contact Axovant directly, please click here. Axovant Sciences, Inc. 320 W 37th St., 5th Floor. New York, NY 10018. Our Culture of Integrity. Resources and Compliance Personnel.
Events and Presentations – Axovant Sciences
http://investors.axovant.com/investors/events-and-presentations
Skip to main content. Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Barclays Global Healthcare Conference. Oppenheimer 27th Annual Healthcare Conference. Cowen and Company 37th Annual Healthcare Conference. RBC Capital Markets 2017 Healthcare Conference. Leerink Partners 6th Annual Global Healthcare Conference. Our Culture of Integrity.
2017 – Axovant Sciences
http://investors.axovant.com/investors/press-releases
Skip to main content. Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Register for email alerts. Axovant Sciences to Present at Upcoming Investor Conferences. Axovant Sciences to Present at Upcoming Investor Conferences. Axovant Sciences Announces $55.0 Million Venture Debt Financing from Hercules Capital. Axovant Sciences Announces Dementia Pipeline Updates an...
Axovant Sciences Announces Pipeline Program Updates and Presentation at 35th Annual J.P. Morgan Conference – Axovant Sciences
http://investors.axovant.com/investors/press-releases/2017/01-09-2017-120305062
Skip to main content. Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Our Culture of Integrity. Resources and Compliance Personnel. REM Sleep Behavior Disorder (RBD). Axovant Sciences Announces Pipeline Program Updates and Presentation at 35th Annual J.P. Morgan Conference. Axovant Sciences Announces Pipeline Program Updates and Presentation at 35th Annual J.P. Morgan Conference. Recruitment in MINDSET study completed. Food and Drug Administration (FDA).
TOTAL PAGES IN THIS WEBSITE
11
Mechanism of Action - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/pipeline/intepirdine-rvt-101/mechanism-of-action
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). Intepirdine (RVT-101) is an orally administered, potent antagonist of the 5HT6 receptor. Blocking the 5HT6 receptor promotes the release of acetylcholine, an essential neurotransmitter needed for normal cognition and function. Together, intepirdine and donepezil may work to preserve acetylcholine and improve the cognition and function of patients with mild to moderate Alzheimer’s disease. 2017 Axovant Sciences ...
Nelotanserin - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/pipeline/nelotanserin
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). We believe that nelotanserin has a number of favorable properties as a product candidate for dementia:. Highly potent and highly selective at the 5HT2A receptor. Minimal or no activity at the 5HT2C, D2 or H1 receptors. Well tolerated in the seven clinical studies completed to date with nearly 800 human subjects exposed to the drug candidate. No evidence of QTc prolongation. Oral, once-daily administration.
REM Sleep Behavior Disorder (RBD) - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/clinical-trials/rem-sleep-behavior-disorder-rbd
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). Axovant is currently conducting a phase 2, multi-center, double-blind, placebo-controlled study evaluating nelotanserin in patients with dementia with Lewy bodies (DLB) experiencing rapid eye movement (REM) sleep behavior disorder (RBD). For more information about the visual hallucinations study evaluating nelotanserin* in patients with Lewy body dementia call 1 (919) 425-0709. Learn More About Nelotanserin.
HEADWAY-DLB - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/clinical-trials/headway-dlb
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). HEADWAY-DLB is a global Phase 2b multi-center, double-blind, placebo-controlled clinical study evaluating intepirdine (RVT-101) in patients with dementia with Lewy bodies (DLB). HEADWAY-DLB is a Phase 2b clinical research study evaluating intepirdine (RVT-101)* for dementia with Lewy bodies. For more information contact us at HEADWAYDLB@Axovant.com. Or call 1 (646) 677-5778. Learn More About Our Clinical Trials.
Board of Directors - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/about/board-of-directors
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). Lawrence Olanoff, MD, PhD. Atul Pande, MD. Marianne L. Romeo. Gary Pisano, PhD. Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). 2017 Axovant Sciences Ltd. Privacy Policy.
Alzheimer's Disease - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/knowledge-center/about-dementia/alzheimers-disease
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). Alzheimer’s disease is the most common form of dementia and the sixth leading cause of death in the United States. Alzheimer’s Association Alzheimer’s Disease Facts and Figures 2014 and 2015; Barnes and Yaffe, Lancet Neurology, 2011 Sep; 10(9): 819-28. In 2015, total healthcare costs for Alzheimer’s and other dementias were $226 billion in the US alone. No new treatment options for patients have been approv...
ABOUT DEMENTIA - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/knowledge-center/about-dementia
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). Dementia is a general term for a group of symptoms caused by disorders that impair at least two brain functions, like memory or judgement. Alzheimer’s disease is the most common type of dementia. Ability to focus and pay attention. Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). 2017 Axovant Sciences Ltd. Privacy Policy.
Our Vision - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/about/our-vision
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). Our vision at Axovant Sciences is to become the leading company focused on the treatment of dementia by comprehensively addressing the cognitive, functional, and behavioral needs of dementia patients. Our mission is to build a pipeline of late stage CNS drugs in a capital efficient manner to deliver value to patients and to shareholders. Learn More About Our Pipeline. Lorem ipsum dolor sit amet.
Leadership Team - Axovant Sciences - A Dementia Solutions Company
http://axovant.com/about/leadership-team
Our Culture of Integrity. Resources & Compliance Personnel. REM Sleep Behavior Disorder (RBD). Axovant has assembled a team with decades of combined experience in developing, obtaining approval, and commercializing drugs for central nervous system disorders. Lawrence T. Friedhoff, MD, PhD, FACP*. Led the development of Aricept (donepezil), the top-selling drug for Alzheimer’s disease in history. Led the new drug approval team for Aciphex (rabeprazole) for the treatment of heartburn. Author of the book.
TOTAL LINKS TO THIS WEBSITE
91
AVG - Security Technology | Investors
The only premium security software that actively seeks out identity theft. Ultimate protection for everything you do online. Exceptional protection that won’t get in your way. Get the most out of your PC. Protect your family online. Check website’s reputation online. It’s an inbox. It’s a social feed. It’s a browser. Hassle-free help for your AVG Software, PC and gadgets. AVG Mobilation For Android Smartphones. AVG Mobilation For Android Tablet. AVG Internet Security Business Edition. Q2 2015 AVG Technol...
Investor Relations - AV Homes, Inc.
Media Inquiry information for AV Homes. AV Homes, Inc. Continue to Investor Relations. Welcome to the AV Homes, Inc. Investor Information Web site. Please read the information below carefully before using this site. By continuing on this site, you acknowledge that you have read and agree to the following:. No Duty to Update -. Annual Reports and Proxies. College Station, TX 77842-3170. Toll Free: (800) 850 3132. International: 1 (201) 680 6578. Jul 30, 2015. Jul 16, 2015. View all ». AV Homes, Inc.
Investor Relations | Aviat Networks
Skip to main navigation. Or join the dialogue at www.twitter.com/aviatnetworks. View our Investor video. Feb 8, 2018. Aviat Networks Announces Second Quarter of Fiscal 2018 Financial Results. Feb 1, 2018. Aviat Networks Sets Date for Its Fiscal 2018 Second Quarter Results. More events are coming soon. View all events and presentations. Stock Price/Detail AVNW (NASDAQ).
Avinger - Investor Relations
Avinger Inc at Canaccord Genuity 35th Annual Growth Conference. 160;at 9:00 am ET. Avinger Inc at Canaccord Genuity 35th Annual Growth Conference. Thursday, August 13, 2015 . 9:00 am ET . Click here for webcast. Click here to add this event to your calendar. 160; 0.55. Data as of 08/14/15 4:00 pm ET. Minimum 20 minute delay. Avinger, Inc. Announces Early 510(k) Filing for Pantheris(TM). Avinger, Inc. Announces Participation in Canaccord Genuity 35th Annual Growth Conference. Avinger, Inc. to Announc...
AVJennings
House and Land Packages. Buying New Homes or Townhomes. Buying a House and Land Package. South West Double Deal. South West Stamp Duty T&Cs. South West $10k Cashback T&Cs. Address Edition No.5. Magnolia Design Rewards T&C’s. First Home Owner Benefits. New Home Grant Scheme. Refer a Friend or Family Member. Lakes Edge - The Ponds. Lakes Edge-Australia's Best Houses. Share Price and Graph. AVJennings in the News. CEO interview with CommSec Opens in new window. As at 3:58PM 12/01/2017. Site by Orient Capital.
Investors – Axovant Sciences
Skip to main content. REM Sleep Behavior Disorder (RBD). REM Sleep Behavior Disorder (RBD). 35th Annual J.P. Morgan Healthcare Conference. More Events and Presentations. Axovant Sciences Announces Pipeline Program Updates and Presentation at 35th Annual J.P. Morgan Conference. Axovant Sciences to Present at the 35th Annual J.P. Morgan Healthcare Conference. For More Press Releases. REM Sleep Behavior Disorder (RBD). 2017 Axovant Sciences Ltd. 2017 Axovant Sciences Ltd.
Axway Finance - Investor Relations
Back to Investors Portal. Axway in the news. Interactive Registration Document 2014. Half-Year Report at 30 June 2014. Nomination, Ethics and Governance Committee. Last trade: August 14th (5:35 pm). Axway: total revenue growth up 17.6% in the first half of 2015. Publication of the 1st Half-Year 2015. Analysts’ Conference of 1st Half-Year 2015. Interactive Registration Document 2014. Why invest in Axway? Essential tools for Axway Shareholders. Axway in the News. Read the latest headlines. August 3rd, 2015.
Axxcess Capital
Axxcess Capital - 4340 Von Karman Avenue, Suite 200, Newport Beach, CA 92660. Investor Services: 877.629.9237. Information on this site is generally believed to be accurate. Should any discrepancies be found the actual executed documents shall prevail.
investors.b12capitalpartners.com
B12 Investors Portal
All information provided is to be kept strictly confidential. Website by Flint Hills Design.
Babcock & Wilcox Company - Investor Overview
Skip to main content. Select your geographic region to submit a sales or service inquiry:. Procurement, Employment and Other / General. Or find your local sales and service phone number. Stock Quote and Chart. Pricing delayed by 20 mins. Mar 29, 2018. Stock Quote and Chart. Established in 1867, Babcock and Wilcox is a global leader in providing custom technologies, engineered solutions, and aftermarket services to a broad range of industrial and power generation customers. End of Day Stock Quote.
Investor Relations | Bactiguard
Positiv volymutveckling och fortsatt fokus på tillväxt. Delårsrapport 1 april - 30 juni 2015. Delårsrapport 1 januari - 31 mars 2015. Phone: 46 (0)8 440 58 80. Fax: 46 (0)8 440 58 90. PO Box 15, S-146 21 Tullinge, Sweden. I samarbete med Alert IR. In cooperation with Alert IR.
SOCIAL ENGAGEMENT